Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010
Identifieur interne : 000738 ( Main/Exploration ); précédent : 000737; suivant : 000739Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010
Auteurs : Abigail Eaton [États-Unis] ; Ned Lewis [États-Unis] ; Bruce Fireman [États-Unis] ; John Hansen [États-Unis] ; Roger Baxter [États-Unis] ; Julianne Gee [États-Unis] ; Nicola P. Klein [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 2017.
Descripteurs français
- KwdFr :
- Adulte, Avortement spontané (épidémiologie), Complications de la grossesse et maladies infectieuses (), Femelle, Grippe humaine (), Grossesse, Humains, Issue de la grossesse (épidémiologie), Mortinaissance (épidémiologie), Naissance prématurée (épidémiologie), Nourrisson petit pour son âge gestationnel, Nourrisson très faible poids naissance, Nouveau-né, Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H1N1 du virus de la grippe A (pathogénicité), Vaccins antigrippaux (usage thérapeutique), Études de cohortes.
- MESH :
- immunologie : Sous-type H1N1 du virus de la grippe A.
- pathogénicité : Sous-type H1N1 du virus de la grippe A.
- usage thérapeutique : Vaccins antigrippaux.
- épidémiologie : Avortement spontané, Issue de la grossesse, Mortinaissance, Naissance prématurée.
- Adulte, Complications de la grossesse et maladies infectieuses, Femelle, Grippe humaine, Grossesse, Humains, Nourrisson petit pour son âge gestationnel, Nourrisson très faible poids naissance, Nouveau-né, Études de cohortes.
English descriptors
- KwdEn :
- Abortion, Spontaneous (epidemiology), Adult, Cohort Studies, Female, Humans, Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza Vaccines (therapeutic use), Influenza, Human (prevention & control), Pregnancy, Pregnancy Complications, Infectious (prevention & control), Pregnancy Outcome (epidemiology), Premature Birth (epidemiology), Stillbirth (epidemiology).
- MESH :
- chemical , therapeutic use : Influenza Vaccines.
- epidemiology : Abortion, Spontaneous, Pregnancy Outcome, Premature Birth, Stillbirth.
- immunology : Influenza A Virus, H1N1 Subtype.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- Adult, Cohort Studies, Female, Humans, Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Pregnancy.
Abstract
Following the H1N1 influenza pandemic in 2009, pregnant women were recommended to receive both seasonal (TIV) and H1N1 influenza vaccines. This study presents incidence of adverse birth and pregnancy outcomes among a population of pregnant women immunized with TIV and H1N1 vaccines at Kaiser Permanente Northern California during 2009–2010.
We telephone surveyed pregnant Kaiser Permanente Northern California members to assess non-medically-attended reactions following H1N1, TIV or both vaccines during 2009–2010 (n = 5365) in a separate study. Here we assessed preterm birth (<37 weeks), very preterm birth (<32 weeks), low birth weight (<2500 g, LBW), very low birth weight (<1500 g), small for gestational age, spontaneous abortions, stillbirths and congenital anomalies among this cohort by comparing incidence and 95% confidence intervals between the following immunization groups: TIV only, H1N1 only, H1N1 prior to TIV immunization, TIV prior to H1N1 and both immunizations given at the same time.
Results did not vary significantly between groups. Comparing H1N1 with TIV, incidence were similar for preterm births (6.37 vs 6.28/100 births), very preterm births (5.30 vs 8.29/1000 births), LBW (4.19 vs 2.90/100 births), very LBW (4.54 vs 5.52/1000 births), small for gestational age (9.99 vs 9.24/1000 births), spontaneous abortion (7.10 vs 6.83/1000 pregnancies), stillbirths (7.10 vs 4.57/1000 pregnancies), and congenital anomalies (2.67 vs 2.43/100 births).
Although constrained by small sample size, complex vaccine groups, and differential vaccine availability during 2009–2010, this study found no difference in adverse birth outcomes between H1N1 vaccine and TIV.
Url:
DOI: 10.1016/j.vaccine.2017.08.080
PubMed: 28917536
PubMed Central: 6708558
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000868
- to stream Pmc, to step Curation: 000868
- to stream Pmc, to step Checkpoint: 000259
- to stream PubMed, to step Corpus: 000371
- to stream PubMed, to step Curation: 000371
- to stream PubMed, to step Checkpoint: 000312
- to stream Ncbi, to step Merge: 001D16
- to stream Ncbi, to step Curation: 001D16
- to stream Ncbi, to step Checkpoint: 001D16
- to stream Main, to step Merge: 000740
- to stream Main, to step Curation: 000738
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010</title><author><name sortKey="Eaton, Abigail" sort="Eaton, Abigail" uniqKey="Eaton A" first="Abigail" last="Eaton">Abigail Eaton</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Lewis, Ned" sort="Lewis, Ned" uniqKey="Lewis N" first="Ned" last="Lewis">Ned Lewis</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Fireman, Bruce" sort="Fireman, Bruce" uniqKey="Fireman B" first="Bruce" last="Fireman">Bruce Fireman</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Hansen, John" sort="Hansen, John" uniqKey="Hansen J" first="John" last="Hansen">John Hansen</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Baxter, Roger" sort="Baxter, Roger" uniqKey="Baxter R" first="Roger" last="Baxter">Roger Baxter</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Gee, Julianne" sort="Gee, Julianne" uniqKey="Gee J" first="Julianne" last="Gee">Julianne Gee</name><affiliation wicri:level="2"><nlm:aff id="A2">Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Klein, Nicola P" sort="Klein, Nicola P" uniqKey="Klein N" first="Nicola P." last="Klein">Nicola P. Klein</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">28917536</idno><idno type="pmc">6708558</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708558</idno><idno type="RBID">PMC:6708558</idno><idno type="doi">10.1016/j.vaccine.2017.08.080</idno><date when="2017">2017</date><idno type="wicri:Area/Pmc/Corpus">000868</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000868</idno><idno type="wicri:Area/Pmc/Curation">000868</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000868</idno><idno type="wicri:Area/Pmc/Checkpoint">000259</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000259</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:28917536</idno><idno type="wicri:Area/PubMed/Corpus">000371</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000371</idno><idno type="wicri:Area/PubMed/Curation">000371</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000371</idno><idno type="wicri:Area/PubMed/Checkpoint">000312</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000312</idno><idno type="wicri:Area/Ncbi/Merge">001D16</idno><idno type="wicri:Area/Ncbi/Curation">001D16</idno><idno type="wicri:Area/Ncbi/Checkpoint">001D16</idno><idno type="wicri:doubleKey">0264-410X:2017:Eaton A:birth:outcomes:following</idno><idno type="wicri:Area/Main/Merge">000740</idno><idno type="wicri:Area/Main/Curation">000738</idno><idno type="wicri:Area/Main/Exploration">000738</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010</title><author><name sortKey="Eaton, Abigail" sort="Eaton, Abigail" uniqKey="Eaton A" first="Abigail" last="Eaton">Abigail Eaton</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Lewis, Ned" sort="Lewis, Ned" uniqKey="Lewis N" first="Ned" last="Lewis">Ned Lewis</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Fireman, Bruce" sort="Fireman, Bruce" uniqKey="Fireman B" first="Bruce" last="Fireman">Bruce Fireman</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Hansen, John" sort="Hansen, John" uniqKey="Hansen J" first="John" last="Hansen">John Hansen</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Baxter, Roger" sort="Baxter, Roger" uniqKey="Baxter R" first="Roger" last="Baxter">Roger Baxter</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Gee, Julianne" sort="Gee, Julianne" uniqKey="Gee J" first="Julianne" last="Gee">Julianne Gee</name><affiliation wicri:level="2"><nlm:aff id="A2">Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Klein, Nicola P" sort="Klein, Nicola P" uniqKey="Klein N" first="Nicola P." last="Klein">Nicola P. Klein</name><affiliation wicri:level="2"><nlm:aff id="A1">Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="ISSN">0264-410X</idno><idno type="eISSN">1873-2518</idno><imprint><date when="2017">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abortion, Spontaneous (epidemiology)</term><term>Adult</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Infant, Newborn</term><term>Infant, Small for Gestational Age</term><term>Infant, Very Low Birth Weight</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (prevention & control)</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnancy Outcome (epidemiology)</term><term>Premature Birth (epidemiology)</term><term>Stillbirth (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Avortement spontané (épidémiologie)</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grossesse</term><term>Humains</term><term>Issue de la grossesse (épidémiologie)</term><term>Mortinaissance (épidémiologie)</term><term>Naissance prématurée (épidémiologie)</term><term>Nourrisson petit pour son âge gestationnel</term><term>Nourrisson très faible poids naissance</term><term>Nouveau-né</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Études de cohortes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Abortion, Spontaneous</term><term>Pregnancy Outcome</term><term>Premature Birth</term><term>Stillbirth</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Avortement spontané</term><term>Issue de la grossesse</term><term>Mortinaissance</term><term>Naissance prématurée</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Infant, Newborn</term><term>Infant, Small for Gestational Age</term><term>Infant, Very Low Birth Weight</term><term>Pregnancy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Complications de la grossesse et maladies infectieuses</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Nourrisson petit pour son âge gestationnel</term><term>Nourrisson très faible poids naissance</term><term>Nouveau-né</term><term>Études de cohortes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P2">Following the H1N1 influenza pandemic in 2009, pregnant women were recommended to receive both seasonal (TIV) and H1N1 influenza vaccines. This study presents incidence of adverse birth and pregnancy outcomes among a population of pregnant women immunized with TIV and H1N1 vaccines at Kaiser Permanente Northern California during 2009–2010.</p></sec><sec id="S2"><title>Methods</title><p id="P3">We telephone surveyed pregnant Kaiser Permanente Northern California members to assess non-medically-attended reactions following H1N1, TIV or both vaccines during 2009–2010 (n = 5365) in a separate study. Here we assessed preterm birth (<37 weeks), very preterm birth (<32 weeks), low birth weight (<2500 g, LBW), very low birth weight (<1500 g), small for gestational age, spontaneous abortions, stillbirths and congenital anomalies among this cohort by comparing incidence and 95% confidence intervals between the following immunization groups: TIV only, H1N1 only, H1N1 prior to TIV immunization, TIV prior to H1N1 and both immunizations given at the same time.</p></sec><sec id="S3"><title>Results</title><p id="P4">Results did not vary significantly between groups. Comparing H1N1 with TIV, incidence were similar for preterm births (6.37 vs 6.28/100 births), very preterm births (5.30 vs 8.29/1000 births), LBW (4.19 vs 2.90/100 births), very LBW (4.54 vs 5.52/1000 births), small for gestational age (9.99 vs 9.24/1000 births), spontaneous abortion (7.10 vs 6.83/1000 pregnancies), stillbirths (7.10 vs 4.57/1000 pregnancies), and congenital anomalies (2.67 vs 2.43/100 births).</p></sec><sec id="S4"><title>Conclusions</title><p id="P5">Although constrained by small sample size, complex vaccine groups, and differential vaccine availability during 2009–2010, this study found no difference in adverse birth outcomes between H1N1 vaccine and TIV.</p></sec></div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li><li>Géorgie (États-Unis)</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Eaton, Abigail" sort="Eaton, Abigail" uniqKey="Eaton A" first="Abigail" last="Eaton">Abigail Eaton</name></region><name sortKey="Baxter, Roger" sort="Baxter, Roger" uniqKey="Baxter R" first="Roger" last="Baxter">Roger Baxter</name><name sortKey="Fireman, Bruce" sort="Fireman, Bruce" uniqKey="Fireman B" first="Bruce" last="Fireman">Bruce Fireman</name><name sortKey="Gee, Julianne" sort="Gee, Julianne" uniqKey="Gee J" first="Julianne" last="Gee">Julianne Gee</name><name sortKey="Hansen, John" sort="Hansen, John" uniqKey="Hansen J" first="John" last="Hansen">John Hansen</name><name sortKey="Klein, Nicola P" sort="Klein, Nicola P" uniqKey="Klein N" first="Nicola P." last="Klein">Nicola P. Klein</name><name sortKey="Lewis, Ned" sort="Lewis, Ned" uniqKey="Lewis N" first="Ned" last="Lewis">Ned Lewis</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000738 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000738 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:6708558
|texte= Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28917536" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |